Annual Meeting on Women’s Cancer

Key Submission Information

• Call for abstracts (domestic and international*) and surgical films: July 7 through Nov. 6, 2020
• New this year, Trials in Progress posters provide an opportunity for members of the SGO research community to present ongoing trials to encourage collaboration and discussion.
• All phases of clinical research (phases I to III, supportive care, nonpharmacologic interventions) submitted as a Trials in Progress abstract. Trials submitted must be ongoing and cannot have reached pre-specified endpoints for analysis. As such, inclusion of results would be improper and is strictly forbidden.
• Late-breaking submissions: Dec. 1, 2020 through Jan. 4, 2021. The accepted late-breaking abstracts will focus on scientific data that has become available since the original abstract submission deadline of Nov. 6, 2020—abstracts already submitted in response to the initial call for abstracts are not eligible for resubmission. Submissions can include preliminary findings if data analysis is still ongoing; however, trials or experiments for which data collection is not yet complete are discouraged. Abstracts should reflect scientific methods and statistical power suitable for a plenary presentation and should not be previously published or presented.

*SGO defines international abstracts as abstracts concerned with the care of women with gynecologic malignancies outside the United States and Canada.

Key Concepts

Special consideration will be given to abstracts involved in the following key concepts:

• Novel therapeutics
• Surgical innovation
• Innovation in translational research
• Innovative office practice
• Gynecologic oncology in the COVID-19 era
• Health equity research

Health equity research includes, but is not limited to:

• Diversity of populations
• Health care access
• Structural barriers to care
• Implementation science related to health equity
• Social determinants of health indicators (economics, education, environment, structural barriers)